Search

everythinglearnresearchcommunity

for

Search:↓

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Chemotherapy significantly lowers Inhibin A levels in breast cancer patients.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

No treatment fully prevents hair loss from chemotherapy yet.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.